Literature DB >> 8992233

The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration.

V Nehls1, R Herrmann.   

Abstract

In the living organism, capillary growth frequently occurs in a fibrin-rich extracellular matrix. The structure and the mechanical properties of fibrin clots are influenced by various macromolecules (i.e., hyaluronic acid and thrombospondin) and also by pH, ionic strength, and thrombin concentrations of the milieu in which they polymerize. The configuration (three-dimensional architecture) and the rigidity of fibrin clots correlate with their opacity measured by spectrophotometric absorbance readings at 350 nm. By using bovine pulmonary artery endothelial cells and bovine fibrinogen, we show here that transparent fibrin clots (A(350) < 1.0), polymerized at > or = pH 7.5 or in the presence of increased thrombin or sodium chloride concentrations, strongly stimulated capillary morphogenesis in vitro. In contrast, opaque fibrin gels (A(350) > 1.5), polymerized at pH 7.2 or in the presence of dextran, stimulated only the migration of endothelial cells but not capillary morphogenesis. We demonstrate that the angiomorphogenic effects of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are strongly dependent on the structure of the fibrin clots. Our findings suggest that bFGF/VEGF primarily stimulate the proliferation of endothelial cells, whereas the three-dimensional architecture of the fibrin matrix is decisive for capillary morphogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8992233     DOI: 10.1006/mvre.1996.0032

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  24 in total

1.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 2.  Bioactive polymer scaffold for fabrication of vascularized engineering tissue.

Authors:  Irza Sukmana
Journal:  J Artif Organs       Date:  2012-04-21       Impact factor: 1.731

Review 3.  Matrix metalloproteinase control of capillary morphogenesis.

Authors:  Cyrus M Ghajar; Steven C George; Andrew J Putnam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

4.  Topology of the heterogeneous nature of the extracellular matrix on stochastic modeling of tumor-induced angiogenesis.

Authors:  Franck Amyot; Alex Small; Hacène Boukari; Kevin Camphausen; Amir Gandjbakhche
Journal:  Microvasc Res       Date:  2007-11-22       Impact factor: 3.514

5.  Engineered microvessels with strong alignment and high lumen density via cell-induced fibrin gel compaction and interstitial flow.

Authors:  Kristen T Morin; Jessica L Dries-Devlin; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2013-11-14       Impact factor: 3.845

Review 6.  Fibrin gels and their clinical and bioengineering applications.

Authors:  Paul A Janmey; Jessamine P Winer; John W Weisel
Journal:  J R Soc Interface       Date:  2009-01-06       Impact factor: 4.118

Review 7.  In vitro models of angiogenesis and vasculogenesis in fibrin gel.

Authors:  Kristen T Morin; Robert T Tranquillo
Journal:  Exp Cell Res       Date:  2013-06-22       Impact factor: 3.905

8.  Antimicrobial drugs encapsulated in fibrin nanoparticles for treating microbial infested wounds.

Authors:  B Maria Alphonsa; P T Sudheesh Kumar; G Praveen; Raja Biswas; K P Chennazhi; R Jayakumar
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200

9.  Geometric control of capillary architecture via cell-matrix mechanical interactions.

Authors:  Jian Sun; Nima Jamilpour; Fei-Yue Wang; Pak Kin Wong
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

10.  Platelet rich fibrin: a novel approach for osseous regeneration.

Authors:  Abhishek Singh; Munish Kohli; Nimish Gupta
Journal:  J Maxillofac Oral Surg       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.